NCT02167620View on ClinicalTrials.gov

Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

March 31, 2018

Conditions
Diabetes Mellitus, Type 2Schizophrenia
Interventions
DRUG

Metformin

Metformin will be dispensed on a biweekly basis, and pill counts conducted at each visit.

DRUG

Placebo

Placebo will be dispensed on a biweekly basis, and pill counts conducted at each visit.

Trial Locations (1)

Unknown

Center for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT02167620 - Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness | Biotech Hunter | Biotech Hunter